HSIC
Henry Schein, Inc.
Medical Distribution · Healthcare · United States
86.44
close · 2026-10-29
value
71
cheaper than peers71
quality
57
stronger fundamentals57
ranked against
Healthcare
value
quality
547 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.72× | 89 |
| forward P/E | 14.43× | 67 |
| EV to EBITDA | 13.94× | 56 |
| price to book | 3.06× | 52 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 8.9% | 79 |
| operating margin | 5.8% | 72 |
| revenue growth | 6.7% | 43 |
| debt to equity | 80.7% | 28 |
4 of 4 measures available
Facts
| market cap | $10B |
| free cash flow | $446.0M |
| employees | 25,000 |
| first trade | 1995-11-03 |
| next earnings | 2026-11-03 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 3.27 | 3.05 | 3.16 | 3.91 |
| free cash flow | $521.0M | $661.0M | $313.0M | $474.0M |
| net income | $398.0M | $390.0M | $416.0M | $538.0M |
| revenue | $13.18B | $12.67B | $12.34B | $12.65B |
| unusual items | -$105.0M | -$110.0M | -$80.0M | -$131.0M |